Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
57 Cards in this Set
- Front
- Back
What is the action of ACE Inhibitors |
Reduces SVR (vasodilation)
Decreases afterload with an increase in CO Decreases risk of HF post MI |
|
What are the s/e of Ace Inhibitors?
|
SE: cough, Hypokalemia, taste disturbance, renal insufficiency, hypotension
|
|
What are the nursing implications for Ace Inhibitors?
|
Monitor s/s HF (I&O, DWT, LS, EDEMA), BP,
|
|
What labs do you monitor?
|
Monitor labs: K, BUN, Creatinine
|
|
What is the expected outcome for Ace Inhibitors?
|
Decrease in s/s HF and BP
Decrease in ventricular remodeling by inhibiting ventricular hypertrophy |
|
What are nursing implications for Antiarrhythmics?
|
Monitor ECG, HR, BP, Lab
Take apical pulse for 1 full minute prior to administering, hold if hr < 50 and call physician |
|
What are the actions of Nitrates?
|
Dilates coronary arteries, Decreases preload, BP, myocardial oxygen consumption
Increases CO |
|
What are the s/e of Nitrates?
|
Dizziness, HA, hypotension, tachycardia
|
|
What are the Nursing Implications for Nitrates?
|
Assess pain characteristics
1 SL NTG q 5 min x 3 Monitor BP, HR, Wear gloves when handling oint., Replace Q6 mo, protect from heat (don’t keep in pockets) Do not take with Viagra |
|
What is the outcome for Nitrates?
|
Decrease in the frequency of angina attacks, Increase in activity tolerance
|
|
What are the actions for Beta Blockers? (olols)
|
Prophylaxis of angina
Decrease myocardial contractility, HR, SVR, & BP, decrease myocardial O2 demand |
|
What are the s/e of Beta Blockers?
|
Can exacerbate HF monitor for s/s of HF,(I/O, DWT,LS,Edema)
|
|
What are the nursing implications for Beta Blockers?
|
Monitor VS, ECG, glucose (can mask signs of hypoglycemia in diabetics), BUN, K
|
|
What is the outcome for Beta Blockers?
|
Decrease in BP, angina, HR. Increase in activity tolerance
|
|
What are the actions for Calcium Channel Blockers?
• Verapamil (Calan) • Diltiazem (Cardizem) |
Coronary & systemic vasodilatation, decreased SVR & myocardial contractility
Inhibits coronary artery spasm (Prinzmetal’s Angina) |
|
What are the s/e and nursing implications for Calcium Channel Blockers?
|
Potentates action of Digoxin
Monitor VS, s/s of HF, ECG |
|
What are the expected outcomes for Calcium Channel Blockers?
|
Decreased BP, decreases angina
Increases activity tolerance |
|
Diuretics Actions
Loop diuretics • Furosemide (Lasix) • Torsemide (Demadex |
Inhibits NaCl reabsorption in the loop of Henle
|
|
What are the s/e and nursing implications for Diuretics?
|
Monitor Lab for F & E imbalances (K, Na, Cl, Mg decreases) VS, Ototoxicity, Hyperglycemia, Orthostatic hypotension
|
|
What are the expected outcomes for Diuretics?
|
Decreased edema (fluid overload)
Increased UOP Decreased BP Lungs clear |
|
What are the actions for Potassium sparing Diuretics?
Spironolactone (Aldactone) |
Reduce K and Na exchange in the distal and collecting tubules
|
|
What are the nursing implications for Potassium sparing diuretics?
|
Monitor labs-can increase K,
VS, N/V/D, Orthostatic hypotension |
|
What are the actions for Glycoprotein IIB/IIIA Inhibitors
RePro,Integrilin? |
Prevents the binding of fibrinogen to platelets, blocking platelet aggregation
Treatment of ACS |
|
What are the nursing implications for Glycoprotein IIB/IIIA Inhibitors?
|
Monitor for S/S of bleeding, including arterial or venous access sites, PTT, H&H,
|
|
What are the expected outcomes for Glycoprotein IIB/IIIA Inhibitors?
|
Inhibition of platelet aggregation-decreased incidence of new MI or Death
|
|
What are the actions of the Low Molecular Weight Heparins
• Dalteparin (Fragmin) • Enoxaparin (Lovenox) |
Prevention of a thromboembolic event (DVT, PE) or ischemic complications in clts with unstable angina or MI
|
|
What are the nursing implications for LMWHs?
|
Monitor PLT, CBC, S/S bleeding
|
|
What are the expected outcomes for LMWHs?
|
Prevention of DVT, PE and ischemic complications in clts with unstable angina
|
|
What is the action for Magnesium Sulfate?
|
Hypomagnesemia. Low magnesium levels may increase cardiac irritability and aggravate cardiac arrhythmias
|
|
What are the nursing implications for Magnesium Sulfate?
|
Monitor HR, BP, Resp, ECG, UOP
|
|
What is the outcome for Magnesium Sulfate?
|
Normal magnesium level of
1.3-2.1 mEq/L No cardiac arrhythmias |
|
What is the action for Potassium Supplements?
K-Dur |
Hypokalemia,
Maintain electrophysiologic balance of the cell Essential in contraction of cardiac muscle |
|
What are the s/e for Potassium Supplements?
|
Arrhythmias, GI upset, IV site irritation,
|
|
What are the nursing implications for Potassium Supplements?
|
Monitor for s/s of hypo & hyperkalemia, potassium level especially during diuretic therapy
With IV infusion monitor pulse, BP, ECG, and IV site |
|
What is the outcome for Potassium Supplements?
|
No cardiac arrhthmias
|
|
What are the actions of the Low Molecular Weight Heparins
• Dalteparin (Fragmin) • Enoxaparin (Lovenox) |
Prevention of a thromboembolic event (DVT, PE) or ischemic complications in clts with unstable angina or MI
|
|
What are the nursing implications for LMWHs?
|
Monitor PLT, CBC, S/S bleeding
|
|
What are the expected outcomes for LMWHs?
|
Prevention of DVT, PE and ischemic complications in clts with unstable angina
|
|
What is the action for Magnesium Sulfate?
|
Hypomagnesemia. Low magnesium levels may increase cardiac irritability and aggravate cardiac arrhythmias
|
|
What are the nursing implications for Magnesium Sulfate?
|
Monitor HR, BP, Resp, ECG, UOP
|
|
What is the outcome for Magnesium Sulfate?
|
Normal magnesium level of
1.3-2.1 mEq/L No cardiac arrhythmias |
|
What is the action for Potassium Supplements?
K-Dur |
Hypokalemia,
Maintain electrophysiologic balance of the cell Essential in contraction of cardiac muscle |
|
What are the s/e for Potassium Supplements?
|
Arrhythmias, GI upset, IV site irritation,
|
|
What are the nursing implications for Potassium Supplements?
|
Monitor for s/s of hypo & hyperkalemia, potassium level especially during diuretic therapy
With IV infusion monitor pulse, BP, ECG, and IV site |
|
What is the outcome for Potassium Supplements?
|
No cardiac arrhthmias
|
|
What are the s/e and nursing implications for Calcium Channel Blockers?
|
Potentates action of Digoxin
Monitor VS, s/s of HF, ECG |
|
What are the expected outcomes for Calcium Channel Blockers?
|
Decreased BP, decreases angina
Increases activity tolerance |
|
Diuretics Actions
Loop diuretics • Furosemide (Lasix) • Torsemide (Demadex |
Inhibits NaCl reabsorption in the loop of Henle
|
|
What are the s/e and nursing implications for Diuretics?
|
Monitor Lab for F & E imbalances (K, Na, Cl, Mg decreases) VS, Ototoxicity, Hyperglycemia, Orthostatic hypotension
|
|
What are the expected outcomes for Diuretics?
|
Decreased edema (fluid overload)
Increased UOP Decreased BP Lungs clear |
|
What are the actions for Potassium sparing Diuretics?
Spironolactone (Aldactone) |
Reduce K and Na exchange in the distal and collecting tubules
|
|
What are the nursing implications for Potassium sparing diuretics?
|
Monitor labs-can increase K,
VS, N/V/D, Orthostatic hypotension |
|
What are the actions for Glycoprotein IIB/IIIA Inhibitors
RePro,Integrilin? |
Prevents the binding of fibrinogen to platelets, blocking platelet aggregation
Treatment of ACS |
|
What are the nursing implications for Glycoprotein IIB/IIIA Inhibitors?
|
Monitor for S/S of bleeding, including arterial or venous access sites, PTT, H&H,
|
|
What are the expected outcomes for Glycoprotein IIB/IIIA Inhibitors?
|
Inhibition of platelet aggregation-decreased incidence of new MI or Death
|
|
What are the actions of
Potassium sparing • Spironolactone (Aldactone |
Reduce K and Na exchange in the distal and collecting tubules
|
|
What are the nursing implications for Potassium sparing
• Spironolactone (Aldactone) |
Monitor labs-can increase K,
VS, N/V/D, Orthostatic hypotension |